ARDX
Price:
$6.82
Market Cap:
$1.61B
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult patients with chronic kidney disease (CKD)on dialysis, or hyperphosphatemia. It is also developing RDX013, a potassium secretagogue, for the treatment of elevated serum potassium, or hyperkalemia, a problem among certain patients with kidney and/or hear...[Read more]
Industry
Biotechnology
IPO Date
2014-06-19
Stock Exchange
NASDAQ
Ticker
ARDX
According to Ardelyx, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.67B. This represents a change of 10.90% compared to the average of 1.50B of the last 4 quarters.
The mean historical Enterprise Value of Ardelyx, Inc. over the last ten years is 397.23M. The current 1.67B Enterprise Value has changed 41.91% with respect to the historical average. Over the past ten years (40 quarters), ARDX's Enterprise Value was at its highest in in the June 2024 quarter at 1.84B. The Enterprise Value was at its lowest in in the June 2022 quarter at 68.16M.
Average
397.23M
Median
332.80M
Minimum
71.07M
Maximum
1.39B
Discovering the peaks and valleys of Ardelyx, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 403.41%
Maximum Annual Enterprise Value = 1.39B
Minimum Annual Increase = -83.82%
Minimum Annual Enterprise Value = 71.07M
Year | Enterprise Value | Change |
---|---|---|
2023 | 1.39B | 255.17% |
2022 | 392.59M | 347.64% |
2021 | 87.70M | -83.82% |
2020 | 541.88M | 51.45% |
2019 | 357.80M | 403.41% |
2018 | 71.07M | -70.10% |
2017 | 237.69M | -51.99% |
2016 | 495.09M | 60.84% |
2015 | 307.81M | 256.65% |
2014 | 86.31M | -43.91% |
The current Enterprise Value of Ardelyx, Inc. (ARDX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
624.88M
5-year avg
554.87M
10-year avg
397.23M
Ardelyx, Inc.’s Enterprise Value is greater than BioLineRx Ltd. (65.81M), greater than Lexicon Pharmaceuticals, Inc. (680.98M), greater than Seres Therapeutics, Inc. (285.81M), less than ImmunityBio, Inc. (3.26B), less than Zura Bio Limited (0), greater than Hepion Pharmaceuticals, Inc. (90.89M), greater than AVROBIO, Inc. (1.81M), greater than Verastem, Inc. (-85302404.00), greater than Mereo BioPharma Group plc (73.99M), greater than Terns Pharmaceuticals, Inc. (595.29M), greater than PDS Biotechnology Corporation (607.04M), greater than Inozyme Pharma, Inc. (103.25M), greater than HOOKIPA Pharma Inc. (355.81M), greater than null (64.03M),
Company | Enterprise Value | Market cap |
---|---|---|
65.81M | $44.18M | |
680.98M | $610.92M | |
285.81M | $144.41M | |
3.26B | $2.39B | |
0 | $279.33M | |
90.89M | $3.77M | |
1.81M | $5.24M | |
-85302404.00 | $115.50M | |
73.99M | $676.56M | |
595.29M | $698.29M | |
607.04M | $136.60M | |
103.25M | $324.34M | |
355.81M | $136.28M | |
64.03M | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ardelyx, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ardelyx, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Ardelyx, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Ardelyx, Inc. (ARDX)?
What is the 3-year average Enterprise Value for Ardelyx, Inc. (ARDX)?
What is the 5-year average Enterprise Value for Ardelyx, Inc. (ARDX)?
How does the current Enterprise Value for Ardelyx, Inc. (ARDX) compare to its historical average?